1090 related articles for article (PubMed ID: 21813474)
1. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
Baeck C; Wei X; Bartneck M; Fech V; Heymann F; Gassler N; Hittatiya K; Eulberg D; Luedde T; Trautwein C; Tacke F
Hepatology; 2014 Mar; 59(3):1060-72. PubMed ID: 24481979
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Wehr A; Baeck C; Ulmer F; Gassler N; Hittatiya K; Luedde T; Neumann UP; Trautwein C; Tacke F
PLoS One; 2014; 9(11):e112327. PubMed ID: 25372401
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
Kudo H; Yata Y; Takahara T; Kawai K; Nakayama Y; Kanayama M; Oya T; Morita S; Sasahara M; Mann DA; Sugiyama T
Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026
[TBL] [Abstract][Full Text] [Related]
5. Spiegelmer Inhibition of MCP-1/CCR2--Potential as an Adjunct Immunosuppressive Therapy in Transplantation.
Kalnins A; Thomas MN; Andrassy M; Müller S; Wagner A; Pratschke S; Rentsch M; Klussmann S; Kauke T; Angele MK; Bazhin AV; Fischereder M; Werner J; Guba M; Andrassy J
Scand J Immunol; 2015 Aug; 82(2):102-9. PubMed ID: 25970072
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
7. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.
Ehling J; Bartneck M; Wei X; Gremse F; Fech V; Möckel D; Baeck C; Hittatiya K; Eulberg D; Luedde T; Kiessling F; Trautwein C; Lammers T; Tacke F
Gut; 2014 Dec; 63(12):1960-1971. PubMed ID: 24561613
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
Zhang S; Wang J; Liu Q; Harnish DC
J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927
[TBL] [Abstract][Full Text] [Related]
9. Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.
Ninichuk V; Clauss S; Kulkarni O; Schmid H; Segerer S; Radomska E; Eulberg D; Buchner K; Selve N; Klussmann S; Anders HJ
Am J Pathol; 2008 Mar; 172(3):628-37. PubMed ID: 18258851
[TBL] [Abstract][Full Text] [Related]
10. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
Miura K; Yang L; van Rooijen N; Ohnishi H; Seki E
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1310-21. PubMed ID: 22442158
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Kassel KM; Guo GL; Tawfik O; Luyendyk JP
Lab Invest; 2010 Dec; 90(12):1794-804. PubMed ID: 20697377
[TBL] [Abstract][Full Text] [Related]
12. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
13. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane A(2) receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment.
Minamino T; Ito Y; Ohkubo H; Hosono K; Suzuki T; Sato T; Ae T; Shibuya A; Sakagami H; Narumiya S; Koizumi W; Majima M
Toxicol Appl Pharmacol; 2012 Feb; 259(1):104-14. PubMed ID: 22206755
[TBL] [Abstract][Full Text] [Related]
15. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
16. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.
Tosello-Trampont AC; Landes SG; Nguyen V; Novobrantseva TI; Hahn YS
J Biol Chem; 2012 Nov; 287(48):40161-72. PubMed ID: 23066023
[TBL] [Abstract][Full Text] [Related]
17. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
Karlmark KR; Weiskirchen R; Zimmermann HW; Gassler N; Ginhoux F; Weber C; Merad M; Luedde T; Trautwein C; Tacke F
Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540
[TBL] [Abstract][Full Text] [Related]
18. CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis.
Sutti S; Locatelli I; Bruzzì S; Jindal A; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2015 Nov; 129(9):797-808. PubMed ID: 26253086
[TBL] [Abstract][Full Text] [Related]
19. Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice.
Kulkarni O; Eulberg D; Selve N; Zöllner S; Allam R; Pawar RD; Pfeiffer S; Segerer S; Klussmann S; Anders HJ
J Pharmacol Exp Ther; 2009 Feb; 328(2):371-7. PubMed ID: 18997060
[TBL] [Abstract][Full Text] [Related]
20. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.
Galastri S; Zamara E; Milani S; Novo E; Provenzano A; Delogu W; Vizzutti F; Sutti S; Locatelli I; Navari N; Vivoli E; Caligiuri A; Pinzani M; Albano E; Parola M; Marra F
Clin Sci (Lond); 2012 Oct; 123(7):459-71. PubMed ID: 22545719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]